Table 1 Baseline characteristics of the patients with subarachnoid hemorrhage
Variables | Development cohort (n = 20) | P value | Validation cohort (n = 20) | P value | ||
|---|---|---|---|---|---|---|
GHD (n = 10) | No-GHD (n = 10) | GHD (n = 10) | No-GHD (n = 10) | |||
Age, y | 52.6 ± 12.195 | 49.6 ± 6.132 | 0.496 | 46.1 ± 10.775 | 50.7 ± 8.629 | 0.306 |
Gender | Â | Â | Â | Â | Â | Â |
 Male, % | 1(10) | 1(10) |  | 3 (30) | 2 (20) |  |
 Female, % | 9(90) | 9(90) |  | 7 (70) | 8 (80) |  |
Aneurysm Location | Â | Â | Â | Â | Â | Â |
 AcoA, % | 6(60) | 3(30) |  | 5 (50) | 4 (40) |  |
 PcoA, % | 2(20) | 3(30) |  | 3 (30) | 3 (30) |  |
 MCA, % | 2(20) | 4(40) |  | 2 (20) | 3 (30) |  |
Aneurysmal size (mm) | 6.22 ± 3.247 | 3.845 ± 0.959 | 0.049 | 5.828 ± 1.516 | 3.197 ± 0.639 | <0.001 |
Hunt & Hess score | 3 (2–4) | 2 (1–3) | 0.063 | 3 (2–4) | 2 (1–4) | 0.009 |
Fisher grade | 4 (2–4) | 3 (1–4) | 0.019 | 4 (3–4) | 2 (1–4) | 0.001 |
BMI | 24 ± 2.867 | 24.2 ± 2.53 | 0.87 | 24.3 ± 2.452 | 24.2 ± 3.765 | 0.945 |
Peak GH (ng/mL) | 3.5 (2.094–6.74) | 11.2 (8.59–13.15) | <0.001 | 5.28 ± 2.077 | 12.223 ± 1.784 | <0.001 |